Foundation Medicine to Present at Morgan Stanley Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. (NASDAQ: FMI) today announced that members of the company's management team will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2015, at 9:55 a.m. EDT in New York City.

A live, listen-only webcast of the presentation may be accessed by visiting the investors section of the company’s website at investors.foundationmedicine.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the company's website for 90 days.

About Foundation Medicine

Foundation Medicine (NASDAQ: FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOne® for solid tumors and FoundationOne® Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine® and FoundationOne® are registered trademarks of Foundation Medicine, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150909005161/en/

Media Contact:
Pure Communications, Inc.
Dan Budwick, 973-271-6085
[email protected]
or
Investor Contact:
Susan Hager, 617-418-2258
[email protected]
or
Matt Clawson, 949-370-8500
[email protected]

Source: Foundation Medicine, Inc.

You May Also Be Interested In

• Morgan Stanley Upgrades Merck (MRK) to Overweight
• Monero Price Prediction Targets $500 While Pepeto Wallets Race the Clock
• SerpApi Surpasses 1.5 Million Activated User Accounts, Empowering Developers Everywhere with Structured Access to the World's Search Data